Remimazolam Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-06-17 10:55:28 -

The Remimazolam Market was valued at approximately USD 500 million in 2024 and is projected to reach USD 1.5 billion by 2035, growing at a CAGR of 10.6%. Remimazolam is an ultra-short-acting benzodiazepine sedative approved for procedural sedation and anesthesia, offering rapid onset and quick recovery profiles that distinguish it from traditional agents like midazolam and propofol. The market...

0 Commentaires 0 Parts 5 Vue 0 Aperçu